Información del producto
ASP2905 is a drug candidate that has been shown to attenuate the symptoms of Alzheimer's disease in mice. It is an orally active compound that binds to the virus's RNA and prevents it from replicating. ASP2905 also inhibits the production of amyloid beta, which are proteins that are believed to be responsible for the development of Alzheimer's disease. ASP2905 has been found to be effective against neuropharmacological disorders in neonatal mice, such as hyperlocomotion. The drug was also found to be effective at mitigating the effects of Parkinson's disease in knockout mice when administered at an effective dose.
Propiedades químicas
Consulta técnica sobre: 3D-SGB18490 ASP2905
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
